Scholars@Duke
Search form
Search
Advanced Search
Support
Index
Subscribe to Announcements
Menu
Search
Home
People
Schools / Institutes
Research
About
Home
People
Schools / Institutes
Research
Phase 1/2b study of Ibrutinib with Carlfizomib with R/R Myeloma
Administered By
Duke Cancer Institute
Awarded By
Pharmacyclics, Inc.
Contributors
Gasparetto, Cristina
Principal Investigator
Start/End
January 20, 2013 - September 16, 2019